Credit: AstraZeneca. Airsupra combines albuterol, a short-acting beta2-agonist, and budesonide, an inhaled corticosteroid. Airsupra ® (albuterol/budesonide) is now available for the as-needed ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...

Budesonide (micronized) 90mcg/inh, 180mcg/inh; dry pwd for inhalation. Pulmicort Flexhaler is available as a dry powder for inhalation containing budesonide in the following 2 strengths: 90 mcg and ...

Please provide your email address to receive an email when new articles are posted on . The study treatment, PT027, is a potential first-in class inhaled, fixed-dose combination rescue medication ...

The researchers evaluated budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol in preventing COPD exacerbations and pneumonia hospitalizations in real-world settings. They ...

Inhaled budesonide (Pulmicort), commonly used in asthma, helped COVID-19 outpatients at extra risk for severe illness recover more quickly relative to standard care in the pragmatic PRINCIPLE trial, ...

LOUISVILLE, Ky. -- An investigational fixed-dose combination of a short-acting beta 2-adrenergic agonist and an inhaled corticosteroid appeared to slow the deterioration in lung function and reduce ...

Budesonide Inhaler Market Size was estimated at USD 4491.44 million in 2021 and is projected to reach USD 5650.14 million by 2028, exhibiting a CAGR of 3.33% during the forecast period. “Budesonide ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

Two drugs are better than one when it comes to stopping asthma attacks in progress, a new clinical trial has found. The study, of more than 3,100 asthma patients, found that a two-drug "rescue" ...